Evidence map›Paper›PMID 33322037›Full record

ArticleInternational journal of molecular sciences2020

Activation of the Ion Channel TRPV4 Induces Epithelial to Mesenchymal Transition in Breast Cancer Cells.

Iman Azimi, Mélanie Robitaille, Kaela Armitage, Choon Leng So, Michael J G Milevskiy, Korinne Northwood, Huai Fang Lim, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Role of CaCancer medicine · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Calcium channels as pharmacological targets for cancer therapy.Clinical and experimental medicine · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. CaInternational journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Syndecan-1 (CD138), Carcinomas and EMT.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Iman AzimiSchool of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, TAS 7005, Australia.ORCID 0000-0001-9477-9999
Mélanie RobitailleSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.ORCID 0000-0001-9354-5162
Kaela ArmitageSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.
Choon Leng SoSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.
Michael J G MilevskiyACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Korinne NorthwoodSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4067, Australia.
Huai Fang LimSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.
Erik W ThompsonInstitute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4102, Australia.ORCID 0000-0002-9723-4924
Sarah J Roberts-ThomsonSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.
Gregory R MonteithSchool of Pharmacy, The University of Queensland, Brisbane, QLD 4102, Australia.
The University of Queensland · AUTranslational Research Institute · AUUniversity of Tasmania · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

National Health and Medical Research Council 1022263 and 1079672
6 · The paper itself

Abstract

Epithelial to mesenchymal transition (EMT) in cancer is important in therapeutic resistance and invasiveness. Calcium signaling is key to the induction of EMT in breast cancer cells. Although inhibition of specific calcium-permeable ion channels regulates the induction of a sub-set of EMT markers in breast cancer cells, it is still unclear if activation of a specific calcium channel can be a driver for the induction of EMT events. In this study, we exploited the availability of a selective pharmacological activator of the calcium-permeable ion channel TRPV4 to assess the direct role of calcium influx in EMT marker induction. Gene association studies revealed a link between TRPV4 and gene-ontologies associated with EMT and poorer relapse-free survival in lymph node-positive basal breast cancers. TRPV4 was an important component of the calcium influx phase induced in MDA-MB-468 breast cancer cells by the EMT inducer epidermal growth factor (EGF). Pharmacological activation of TRPV4 then drove the induction of a variety of EMT markers in breast cancer cells. These studies demonstrate that calcium influx through specific pathways appears to be sufficient to trigger EMT events.

Indexed as

Epithelial-Mesenchymal TransitionBreast NeoplasmsCalciumCell Line, TumorFemaleHumansLeucineSulfonamidesSurvival AnalysisTRPV Cation ChannelsCalciumLeucineN-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamideSulfonamidesTRPV4 protein, humanTRPV Cation Channelsbreast cancercalcium channelEMTTRPV4

Identifiers

PMID33322037
PMCPMC7764818
OpenAlexW3112514611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.